Last, in the context of a better understanding of the correlation between pathology and symptoms of AD, a combined analysis that incorporates biomarker‐based examinations of amyloid β or tau levels90 would be preferable.21, 91. This evidence concerns the gene MAPT and Alzheimer disease.